HighTower Advisors
NVAX icon

HighTower Advisors’s Novavax NVAX Stock Holding History

HighTower Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200
Closed -$3K – 3318
2022
Q2 		$3K Buy
+200
New +$10.4K ﹤0.01% 3150
2021
Q3 		– Sell
-200
Closed -$3K – 3356
2021
Q2 		$3K Buy
+200
New +$36.6K ﹤0.01% 3054
2018
Q2 		– Sell
-100
Closed -$1K – 2346
2018
Q1 		$1K Sell
100
-100
-50% -$4.02K ﹤0.01% 2173
2017
Q4 		$1K Buy
+200
New +$4.88K ﹤0.01% 2259
2017
Q3 		– Sell
-100
Closed -$1K – 2323
2017
Q2 		$1K Buy
+100
New +$1.96K ﹤0.01% 2200
2016
Q3 		– Sell
-50
Closed -$1K – 1931
2016
Q2 		$1K Buy
+50
New +$5.73K ﹤0.01% 1757

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HighTower Advisors's NVAX Position: Q3 2022 in Review

HighTower Advisors sold out of Novavax (NVAX) in Q3 2022, closing a stake of 5,627 shares — an estimated $290K sold.

HighTower Advisors first reported a position in NVAX in Q2 2013 and held it in 32 quarters. The position peaked at $1.19M in Q4 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • HighTower Advisors reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 5,627 Novavax shares in Q3 2022, an estimated $290K.
  • HighTower Advisors first reported a position in Novavax in Q2 2013 and held it in 32 quarters.
  • HighTower Advisors's Novavax position peaked at $1.19M in Q4 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.